JHVEPhoto/iStock Editorial via Getty Images
- Veeva Systems is off ~2% Monday after Takeda Pharmaceutical (NYSE:TAK)(OTCPK:TKPHF) chose the Salesforce (NYSE:CRM) Life Sciences Cloud for Customer Engagement.
- The service is “designed to unify data and engagement across the entire organization,” according to a news release. Takeda will also use Salesforce’s Agentforce and Data Cloud “to deploy personalized AI agents, supporting operations from medical to commercial and patient support functions.”
- KeyBanc Capital Markets analyst Scott Schoenhaus, who rates Veeva at overweight, said that despite the setback, he expects that Veeva will keep the “vast majority” of its CRM customers, adding that most of the “top 20 pharma companies” will decide on whether to migrate to Vault CRM in 2025 and 2026.